Home » Education » SARC Talk Podcast
Welcome to SARC Talk, our monthly podcast. Hosted by SARC‘s Chief Medical Officer, Dr. Scott Okuno, SARC Talk explores all things related to sarcoma, including interviews with sarcoma researchers, discussions of innovative scientific initiatives in the field of sarcoma, and updates on the activities of SARC.
Subscribe and listen: Spotify | YouTube | Apple Podcast
Upcoming SARC Talk guests include: – Brian Crompton, MD – Candace Haddox, MD – Sarcoma Sisters Podcast Co-Facilitators Lisa Kopp, DO, MPH and Wendy Allen-Rhoades, MD, PhD
Listen to Season 1
This episode of SARC Talk features Dr. David Kirsch, MD, PhD, a Radiation Oncologist from the University of Toronto. In this episode, Dr. Kirsch sheds light on the vital role of radiation oncology in sarcoma, including clinical trial opportunities and the future of the field. Tune in for an insightful conversation that will deepen your understanding of the intersection between sarcoma and radiation oncology.
Spotify | YouTube | Apple Podcast
This episode features SARC’s CEO and President Steven Young. Steven speaks all about SARC, past, present, and future. In this episode, he shares insights into the challenges faced, the milestones achieved, and the values that have guided SARC through the years. Looking ahead, Steven paints a vivid picture of the exciting future that lies ahead for SARC. He discusses innovative projects, upcoming initiatives, and the organization’s commitment to making a positive impact on the sarcoma community.
This episode showcases Dr. Albiruni Razak from the University of Toronto, Princess Margaret Cancer Center, and Dr. Neeta Somaiah from MD Anderson Cancer Center. Both experts bring a wealth of sarcoma knowledge, particularly focusing on well-differentiated and dedifferentiated liposarcoma. Dr. Razak and Dr. Somaiah delve into the complexities of diagnosing and treating liposarcoma, shedding light on the nuances of managing this rare type of cancer. Their discussion highlights the importance of multidisciplinary collaboration in providing the best care for patients. The conversation also touches on the promising advancements in research, such as targeted therapies and immunotherapies. By sharing their expertise and insights, they aim to improve outcomes and quality of life for individuals facing this challenging disease.